| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| TAX PREPARATION FEE | 1,000 | 1,000 | 1,000 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| CASSAVA SCIENCES | 11,735 | 6,820 |
| CRISPR TECHNOLOGIES | 9,893 | 30,622 |
| Item No. | 1 |
|---|---|
| Lender's Name | RBC LLC |
| Lender's Title | |
| Relationship to Insider | NONE |
| Original Amount of Loan | 4,353 |
| Balance Due | 4,353 |
| Date of Note | 2020-07 |
| Maturity Date | |
| Repayment Terms | MARGIN NOTE |
| Interest Rate | 1 |
| Security Provided by Borrower | SECURITIES |
| Purpose of Loan | FUND EXPENSES AND CONTRIBUTION |
| Description of Lender Consideration | NONE |
| Consideration FMV | 0 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| ARTWORK | 3,600 | 3,600 | 3,600 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| CORPORATE SERVICE FEE | 298 | 298 | 298 | 0 |
| BANK SERVICE CHARGE | 30 | 30 | 30 | 0 |